Author:
Laskari K.,Tektonidou M.G.,Katsiari C.,Athanassiou P.,Dimopoulou D.,Gerodimos C.,Salamaliki C.,Papagoras C.,Settas L.,Vassilopoulos D.,Voulgari P.V.,Zakalka M.,Georgiadis A.,Gkoni G.,Daoussis D.,Dimitroulas T.,Iliou C.,Kallitsakis I.,Grika E.P.,Mavragani C.,Pikazis D.,Raftakis J.,Sarikoudis T.,Kougkas N.,Soukera D.,Theodorou E.,Tsatsani P.,Tsiakou E.,Vlachoyiannopoulos P.,Vosvotekas G.,Sfikakis P.P.
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference26 articles.
1. Treating inflammation by blocking interleukin-1 in humans;Dinarello;Semin Immunol,2013
2. Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review);Junge;Semin Arthritis Rheum,2017
3. Canakinumab for treatment of adult-onset still's disease to achieve reduction of arthritic manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial;Kedor;ARD,2020
4. PRINTO; PRCSG. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis;Ruperto;N Engl J Med,2012
5. Paediatric Rheumatology International Clinical Trials Organisation. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features;Ruperto;Arthritis Rheum,2012
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献